ArticleAmerican journal of hematology2014

Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.

Sarah A Buckley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.